Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Department of Neurosurgery, Mayo Clinic Health System, La Crosse, Wisconsin, USA.
World Neurosurg. 2021 May;149:e989-e1000. doi: 10.1016/j.wneu.2021.01.060. Epub 2021 Jan 28.
We used a data-driven methodology to decrease the departmental surgical site infection rate to a goal of 1%.
A prospective interventional study with historical controls comparing preimplementation/intervention (unknown methicillin-sensitive Staphylococcus aureus [MSSA]/methicillin-resistant Staphylococcus aureus [MRSA] status and standard weight and drug allergy-based preoperative antibiotics) with postimplementation/intervention (optimized preoperative chlorhexidine showers, MSSA/MRSA screening, MSSA/MRSA decolonization, and optimized preoperative antibiotic order set implementation). The American College of Surgeons National Surgical Quality Improvement Program was used for case surveillance. The primary outcome was the presence of a surgical site infection with a secondary outcome of cost(s) of implementation.
A total of 317 National Surgical Quality Improvement Program abstracted neurosurgical cases were analyzed, 163 cases before implementation and 154 cases after implementation. There were no significant differences between the preimplementation and postimplementation cohorts regarding patient demographics and baseline comorbidities, with the exceptions of inpatient and functional status (P < 0.001). The most common procedures were lumbar decompression (31%), lumbar discectomy (27%), and anterior cervical discectomy and fusion (10.4%). After implementation, 30 patients were MSSA positive (20%) and 4 MRSA positive (2.6%). Thirty patients received preoperative intranasal mupirocin decolonization (88%), and 4 patients received adjusted preoperative antibiotics (12%). After protocol implementation, the surgical site infection rate decreased from 6.7% (odds ratio, 2.82) to 0.96% (odds ratio, 0.91). The cost of implementation was $27,179, or $58 per patient.
The findings highlight the importance of systematically investigating areas of gap in existing clinical practice and quality improvement projects to increase patient safety and enhance the value of care delivered to neurosurgical patients.
我们使用数据驱动的方法将部门手术部位感染率降低到 1%。
采用前瞻性干预研究,以历史对照比较实施前/干预前(未知的甲氧西林敏感金黄色葡萄球菌[MSSA]/耐甲氧西林金黄色葡萄球菌[MRSA]状态和基于标准体重和药物过敏的术前抗生素)与实施后/干预后(优化的术前洗必泰淋浴、MSSA/MRSA 筛查、MSSA/MRSA 去定植和优化的术前抗生素医嘱集实施)。美国外科医师学会国家手术质量改进计划用于病例监测。主要结果是存在手术部位感染,次要结果是实施成本。
共分析了 317 例美国外科医师学会国家手术质量改进计划摘录的神经外科病例,实施前 163 例,实施后 154 例。在患者人口统计学和基线合并症方面,实施前和实施后队列之间没有显著差异,除了住院和功能状态(P<0.001)。最常见的手术是腰椎减压术(31%)、腰椎间盘切除术(27%)和前路颈椎间盘切除术和融合术(10.4%)。实施后,30 例患者 MSSA 阳性(20%),4 例 MRSA 阳性(2.6%)。30 例患者接受术前鼻内莫匹罗星去定植(88%),4 例患者接受调整后的术前抗生素(12%)。实施方案后,手术部位感染率从 6.7%(比值比,2.82)下降至 0.96%(比值比,0.91)。实施成本为 27179 美元,或每位患者 58 美元。
研究结果强调了系统调查现有临床实践和质量改进项目中差距领域的重要性,以提高患者安全性并提高向神经外科患者提供的护理价值。